der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY)
- PMID: 12880963
- DOI: 10.1016/s0304-3835(03)00083-1
der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY)
Abstract
Conventional cytogenetic, molecular cytogenic and genetic methods disclosed a broad spectrum of genetic abnormalities leading to gain and loss of chromosomal segments in advanced stage neuroblastoma (NBL). Specific correlation between the genetic findings could delineate distinct genetic pathways, of which the biology and prognostic significance is as yet undetermined. Using spectral karyotyping (SKY) and fluorescence in situ hybridization (FISH) on metaphases from 16 patients with advanced stage NBL, it was possible to explore the whole spectrum of rearrangement within complex karyotypes and to detect hidden recurrent translocations. All translocations were unbalanced. The most prevalent recurrent unbalanced translocations resulted in 17q gain in 12 patients (75%), 11q loss in nine patients (56%), and 1p deletion/imbalance in eight patients (50%). The most frequent recurrent translocation was der(11)t(11;17) in six patients. Three cytogenetic pathways could be delineated. The first, with six patients, was characterized by the unbalanced translocation der(11)t(11;17), detected only by SKY, resulting in the concomitant 17q gain and 11q loss. No MYCN amplification or 1p deletion (except one patient with 1p imbalance) were found, while 3p deletion, and complex karyotypes were common. The second subgroup, with four patients, had 17q gain and 1p deletion, and in two patients 11q loss, that was apparent only by FISH. 1p deletion occurred through der(1)t(1;17) or del(1p). The third subgroup of four patients was characterized by MYCN amplification with 17q gain and 1p deletion, very rarely with 11q loss (one patient) through a translocation with a non-17q partner. The SKY subclassifications were in accordance with the findings reported by molecular genetic techniques, and may indicate that distinct oncogenes and suppressor genes are involved in the der(11)t(11;17) pathway of advanced stage NBL.
Similar articles
-
Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.Genes Chromosomes Cancer. 2002 Jul;34(3):313-24. doi: 10.1002/gcc.10082. Genes Chromosomes Cancer. 2002. PMID: 12007192
-
Promiscuous translocations of chromosome arm 17q in human neuroblastomas.Genes Chromosomes Cancer. 1997 Jul;19(3):143-9. Genes Chromosomes Cancer. 1997. PMID: 9218994
-
Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.Cancer Genet Cytogenet. 2004 Oct 1;154(1):44-51. doi: 10.1016/j.cancergencyto.2004.04.003. Cancer Genet Cytogenet. 2004. PMID: 15381371
-
Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.Carcinogenesis. 2004 Sep;25(9):1599-609. doi: 10.1093/carcin/bgh173. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090470 Review.
-
[The neuroblastoma, "enfant terrible" among pediatric tumors].Verh K Acad Geneeskd Belg. 2003;65(1):5-23; discussion 23-8. Verh K Acad Geneeskd Belg. 2003. PMID: 12802894 Review. Dutch.
Cited by
-
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.Am J Pathol. 2010 Jun;176(6):2616-25. doi: 10.2353/ajpath.2010.090624. Epub 2010 Apr 15. Am J Pathol. 2010. PMID: 20395439 Free PMC article.
-
17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications.Cancers (Basel). 2024 Jan 12;16(2):338. doi: 10.3390/cancers16020338. Cancers (Basel). 2024. PMID: 38254827 Free PMC article. Review.
-
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.Clin Cancer Res. 2010 Jun 1;16(11):2971-8. doi: 10.1158/1078-0432.CCR-09-3215. Epub 2010 Apr 20. Clin Cancer Res. 2010. PMID: 20406844 Free PMC article.
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.Nat Commun. 2020 Oct 14;11(1):5183. doi: 10.1038/s41467-020-18987-4. Nat Commun. 2020. PMID: 33056981 Free PMC article.
-
The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Pediatr Surg Int. 2013 Feb;29(2):101-19. doi: 10.1007/s00383-012-3239-7. Epub 2012 Dec 29. Pediatr Surg Int. 2013. PMID: 23274701 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical